Type
Web site contribution
Title
Indian Pharma: A Global Leader Under Pressure
In
Institut Montaigne
Author(s)
JAFFRELOT Christophe - Centre de recherches internationales (Author)
JUMLE Vihang - WWF India (Author)
KISHOR Maitreyee - Ashoka University (Author)
Keywords
India, Covid-19, pharmaceutical industry
Abstract
EN
India is a global supplier of generic drugs. Its export-oriented pharmaceutical industry is extremely profitable but encounters a number of challenges, from domestic demand to human resources. The Covid-19 pandemic has brought to light its dependence on imports from China of active pharmaceutical ingredients and chemical intermediates. As the whole world discusses how to increase the resilience of supply chains, could this be an opportunity for a Europe-India cooperation? This is the theme of the last article of our new series on India’s health sector, by Christophe Jaffrelot, Senior Research Fellow at CERI-SciencesPo/CNRS, Vihang Jumle, Project Officer at TRAFFIC WWF India and Maitreyee Kishor, a Sciences Po graduate who works at Ashoka University's Centre for Writing and Communication.

BIBLIOGRAPHIC QUOTE
EXPORT